Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Serous Retinopathy Associated with Mitogen-Activated Protein Kinase Kinase Inhibition (Binimetinib) for Metastatic Cutaneous and Uveal Melanoma.
van Dijk EH, van Herpen CM, Marinkovic M, Haanen JB, Amundson D, Luyten GP, Jager MJ, Kapiteijn EH, Keunen JE, Adamus G, Boon CJ. van Dijk EH, et al. Among authors: luyten gp. Ophthalmology. 2015 Sep;122(9):1907-16. doi: 10.1016/j.ophtha.2015.05.027. Epub 2015 Jun 26. Ophthalmology. 2015. PMID: 26123090 Clinical Trial.
Ruthenium-106 brachytherapy for iris and iridociliary melanomas.
Marinkovic M, Horeweg N, Laman MS, Bleeker JC, Ketelaars M, Peters FP, Luyten GPM, Creutzberg CL. Marinkovic M, et al. Br J Ophthalmol. 2018 Aug;102(8):1154-1159. doi: 10.1136/bjophthalmol-2017-310688. Epub 2017 Nov 9. Br J Ophthalmol. 2018. PMID: 29122824
Two Late Recurrences of Conjunctival Melanoma.
Brouwer NJ, Genders SW, Marinkovic M, van Duinen SG, Jager MJ, Luyten GPM. Brouwer NJ, et al. Ocul Oncol Pathol. 2019 Jun;5(4):262-266. doi: 10.1159/000494978. Epub 2018 Dec 12. Ocul Oncol Pathol. 2019. PMID: 31367588 Free PMC article.
MR-based follow-up after brachytherapy and proton beam therapy in uveal melanoma.
Tang MCY, Ferreira TA, Marinkovic M, Jaarsma-Coes MG, Klaassen L, Vu THK, Creutzberg CL, Rodrigues MF, Horeweg N, Klaver YLB, Rasch CRN, Luyten GPM, Beenakker JM. Tang MCY, et al. Among authors: luyten gpm. Neuroradiology. 2023 Aug;65(8):1271-1285. doi: 10.1007/s00234-023-03166-1. Epub 2023 May 30. Neuroradiology. 2023. PMID: 37249621 Free PMC article.
Effectiveness of fractionated stereotactic radiotherapy for uveal melanoma.
Muller K, Nowak PJ, de Pan C, Marijnissen JP, Paridaens DA, Levendag P, Luyten GP. Muller K, et al. Among authors: luyten gp. Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):116-22. doi: 10.1016/j.ijrobp.2005.01.058. Int J Radiat Oncol Biol Phys. 2005. PMID: 16111579 Clinical Trial.
Lacrimal gland radiosensitivity in uveal melanoma patients.
Muller K, Nowak PJ, Naus N, de Pan C, van Santen CA, Levendag P, Luyten GP. Muller K, et al. Among authors: luyten gp. Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):497-502. doi: 10.1016/j.ijrobp.2008.08.010. Epub 2008 Oct 28. Int J Radiat Oncol Biol Phys. 2009. PMID: 18963540 Clinical Trial.
Fractionated stereotactic radiotherapy for uveal melanoma, late clinical results.
Muller K, Naus N, Nowak PJ, Schmitz PI, de Pan C, van Santen CA, Marijnissen JP, Paridaens DA, Levendag PC, Luyten GP. Muller K, et al. Among authors: luyten gp. Radiother Oncol. 2012 Feb;102(2):219-24. doi: 10.1016/j.radonc.2011.06.038. Epub 2011 Aug 22. Radiother Oncol. 2012. PMID: 21864922
190 results